(MedPage Today) — The FDA approved budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) in a single inhaler as maintenance therapy for asthma in adults and children 12 years and up, AstraZeneca announced on Tuesday.
Approval of…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
